ARCHIVES

Five Contracts Funded Under Unconventional Innovations Program

This article is from The Cancer Letter archive.

Vol. 25 No. 40 | October 22, 1999

Download PDF Visit The Full Archive

Related Articles

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

The Number of Adult Cooperative Groups Drops to Four As NSABP, RTOG And GOG Agree to Merge

October 21, 2011